Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apellis Pharmaceuticals (APLS) Debt Ratio (2024 - 2025)

Apellis Pharmaceuticals has reported Debt Ratio over the past 2 years, most recently at 0.42 for Q4 2025.

  • Quarterly results put Debt Ratio at 0.42 for Q4 2025, up 4.25% from a year ago — trailing twelve months through Dec 2025 was 0.42 (up 4.25% YoY), and the annual figure for FY2025 was 0.42, up 4.25%.
  • Debt Ratio for Q4 2025 was 0.42 at Apellis Pharmaceuticals, down from 0.43 in the prior quarter.
  • Over the last five years, Debt Ratio for APLS hit a ceiling of 0.45 in Q1 2025 and a floor of 0.4 in Q3 2024.